Arcadia Biosciences achieves record revenue of $8M despite coronavirus pandemic - Video

Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) CEO Matt Plavan tells Proactive the group posted fourth-quarter results on Wednesday that saw its 2020 revenue increase sixfold to $8M from 2019, despite the impact of the coronavirus pandemic.